Detalles de la búsqueda
1.
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real-world database.
Int J Cancer
; 152(5): 921-931, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36161271
2.
Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program.
Oncologist
; 28(10): e867-e876, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37589218
3.
Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database.
BMC Med
; 21(1): 87, 2023 03 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36882736
4.
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
Br J Cancer
; 127(11): 1963-1973, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36207609
5.
Real-life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program.
Int J Cancer
; 145(12): 3359-3369, 2019 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31087564
6.
Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort.
Br J Cancer
; 121(12): 991-1000, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31719684
7.
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens.
Breast Cancer Res Treat
; 173(2): 397-406, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30357526
8.
Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis.
Ann Surg Oncol
; 26(2): 356-365, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30539492
9.
Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort.
Breast Cancer
; 30(2): 329-341, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36630013
10.
Long-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study.
Cancers (Basel)
; 15(4)2023 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36831532
11.
Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort.
Eur J Cancer
; 189: 112935, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37385070
12.
Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach.
Cancer Chemother Pharmacol
; 89(2): 197-208, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34997290
13.
Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME database.
Ther Adv Med Oncol
; 14: 17588359221077082, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35237352
14.
Impact of lobular versus ductal histology on overall survival in metastatic breast cancer: a French retrospective multicentre cohort study.
Eur J Cancer
; 164: 70-79, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35176614
15.
Efficacy of trastuzumab emtansine (T-DM1) and lapatinib after dual HER2 inhibition with trastuzumab and pertuzumab in patient with metastatic breast cancer: Retrospective data from a French multicenter real-life cohort.
Breast
; 63: 54-60, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35299035
16.
Comparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France.
JAMA Netw Open
; 5(9): e2231170, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36107428
17.
Efficacy of taxanes rechallenge in first-line treatment of early metastatic relapse of patients with HER2-negative breast cancer previously treated with a (neo)adjuvant taxanes regimen: A multicentre retrospective observational study.
Breast
; 65: 136-144, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35944353
18.
Real-world evidence of the management and prognosis of young women (⩽40 years) with de novo metastatic breast cancer.
Ther Adv Med Oncol
; 14: 17588359211070362, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35082924
19.
Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer.
Health Qual Life Outcomes
; 9: 70, 2011 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-21859485
20.
Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program.
Ther Adv Med Oncol
; 13: 1758835920987657, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33613700